Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES（2023）
关键词
Gilteritinib,Acute myeloid leukemia (AML),Early access,Real-life data,Response,Prognosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要